Menu
DIA Europe 2027 • Basel, Switzerland
Press & Media
DIA Europe 2027 is the largest neutral European forum in the life sciences field, designed to advance health priorities and drive insights into action by connecting key policy discussions to real-world knowledge and urgent unmet needs.
In the News
Articles from Previous DIA Europe Conferences
📰 Coverage from past conferences
- African Medicines Agency Will Play Key Role in Continental Regulatory Ecosystem Alongside Regional Initiatives and National Authorities
- European Commission, EMA, and Competent Authorities Lead “Coalition of the Willing” in Addressing Interfaces Between Drug / Device / IVD Regulations
- FDA Europe Office 2024 Priorities for Medical Products Include Promoting Global Regulatory Convergence Around Cutting-Edge Technologies
- MHRA’s Chief Partnerships Officer Explains How the Agency Is Supporting Sustainability
- WHO and EMA Leaders Shed Light on WHO Listed Authorities (WLA) Initiative to Increase Global Regulatory Capabilities
- In focus with Emer Cooke – Executive Director, European Medicines Agency (EMA)
- DARWIN EU ‘ramping up quickly’ with more partners coming on board
- Decentralized trials getting some attention on the international regulatory front
- EMA official shares lessons learned from the COVID pandemic
- Pharma official: Expect “substantial” revision of ICH stability and specification guidelines
- Remote inspections are the new normal, say global regulators
- EMA’s quality innovation group helps to propel regulatory path for novel technologies
- Interview: EMA’s Peter Arlett reflects on RWE approvals, early learnings from DARWIN
- Europe’s Ad Hoc Pandemic Response Highlights Supply Chain Weaknesses
- EU Fine-Tunes Guidance For New Clinical Trials System
- Italy Opens Up On Trial Woes In A Pandemic
- EMA Takes A Dive Into Patient-Level Data
- ‘Open & Constructive’: Early Feedback Supports Simultaneous Scientific Advice In Europe
- EU’s Joint Regulatory/HTA System Praised, But Improvements Needed
Accreditation
Media Registration Guidelines
Media registration is open to editors and reporters working full-time for print, broadcast, or web publications with valid press credentials.
Valid press credentials include:
- A bylined article published by your employing news outlet within the past six months
- A copy of news outlet masthead listing your primary role as an editor or reporter
- Copy of official reporter/editor photo credential issued by news outlet or government
Bloggers are considered for media credentialing on a case-by-case basis and must provide three of their most recent blog posts on a biotechnology-related subject to be considered for registration.
Freelance journalists may apply for complimentary media registration and must present:
- A signed letter on company letterhead from your assignment editor confirming your assignment to cover the event
- A bylined story from the publication you are freelancing for dated within the last six months
Please note that marketing executives, sales representatives, public relations executives, analysts, consultants, authors, and researchers may not register as media.
To register, please contact:
Customer Service — Basel@diaglobal.org
DIA reserves the right to deny media registration to any individual who does not meet the above guidelines, or to limit the amount of media registrants from any one publication.
DIA reserves the right to request a copy of convention coverage as a requirement for media registration.